Patients Helping Patients
- This event has passed.
PFW Special Clinical Trial Meeting – March 13, 2025
March 13 @ 10:00 am – 11:30 am CDT
Join us to learn about MIST, a phase 2b study for people living with progressive pulmonary fibrosis (PPF).
Topics to be discussed:
- 🔹 Introduction to Avalyn Pharma
- 🔹 Brief review of data from prior studies with Pirfenidone Solution for Inhalation
- 🔹 Overview of the MIST 2b Study, including qualification criteria and information on locating study sites
Whether you’re a patient, caregiver, or healthcare professional, we hope you can join us for this important conversation on advancing care with progressive pulmonary fibrosis.
A short Q&A session with Craig Conoscenti, MD, FCCP, ATSF and Rebecca Weaver, APRN will follow the presentation. Please email your questions in advance to Meetings@PFWarrior.com.
PF Warriors
Become a PF Warriors Member!
Membership is always FREE! By becoming a member of the PF Warriors community, you will gain exclusive access to incredible resources designed to support and empower you on your journey with pulmonary fibrosis.
As a member, you will:
- 🔹 Receive advance notifications of upcoming meetings, webinars and events so you never miss out on important discussions like this one.
- 🔹 Get full access to over 100 recorded meetings featuring expert presentations on everything from treatment options and research breakthroughs to lifestyle tips and emotional support, helping you live your best life with pulmonary fibrosis.
- 🔹 Join for FREE! Signing up is quick and easy, and you’ll instantly become part of a supportive network of fellow patients, caregivers, and medical professionals.
What is Pulmonary Fibrosis?
Pulmonary fibrosis is a progressive lung disorder characterized by the formation of scar tissue in the lungs. This scarring leads to breathing difficulties, diminished lung function, and lower oxygen levels in the bloodstream. While currently incurable, there are treatments available to manage symptoms and improve quality of life.
